(Q46376603)

English

Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

author name string

Peter H Jones

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

Harold E Bays

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

Michael H Davidson

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

Maureen T Kelly

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

Susan M Buttler

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

Carolyn M Setze

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

Darryl J Sleep

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

James C Stolzenbach

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

28

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

10

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

625-634

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards of medical care in diabetes--2007.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by rep

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing prevalence of the metabolic syndrome among u.s. Adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statin-fibrate combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The complex role of triglycerides in cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy of dyslipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contemporary management of dyslipidemia in high-risk patients: targets still not met

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statin-fibrate combination: therapy for hyperlipidemia: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal treatment of dyslipidemia in high-risk patients: intensive statin treatment or combination therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triglycerides and the Risk of Coronary Heart Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of cardiovascular events in patients at optimal values for combined lipid parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Managing dyslipidemia in the high-risk patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deaths: final data for 2004.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18783301

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200828100-00003

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/18783301

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46376603&oldid=2108688542"